Key Drivers
- High Margins
- Strong Cash Flow
- Tight Liquidity
AIAI Summary
CHE is now a two-speed story where VITAS is driving the earnings beat and guidance raise, but ongoing Roto-Rooter margin erosion plus tighter liquidity mean the stock's premium valuation leaves little room for disappointment, so investors should treat the recent rally as dependent on sustained hospice execution rather than broad-based strength.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High Margins
- •Strong Cash Flow
- •Tight Liquidity
CHE shows strong profitability and cash flow, but its premium valuation and weaker near-term liquidity/debt profile limit upside.
Price Behavior
Key Price Behavior Insights:
- •Higher lows
- •Range breakout
- •Extended rally
CHE's last month has turned bullish as it broke out of a late-April base, made higher lows, and held momentum above $421-$425, though the sharp run leaves it somewhat extended and prone to a pause or pullback.
Sharp rally from a late-April base has left the stock somewhat extended
Sentiment & News
Key News Insights:
- •Earnings beat
- •Guidance raised
- •Margin pressure
Chemed's Q1 beat and raised guidance lifted the stock despite ongoing margin compression and mixed segment performance, with VITAS outperforming while Roto-Rooter weakened.
The news is modestly positive for CHE in the near term, as investor focus appears to be on the earnings beat and higher outlook rather than the softer margins
Similar Companies in Healthcare
Other companies in the same sector with AI ratings